Clinical Trial Update: Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating rosuvastatin alone or with ezetimibe to reach LDL-C goals in patients with recent ischemic stroke; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Keun-Sik Hong | Conditions: Stroke, Ischemic | Phase 4 | Status: COMPLETED